Market Place
Sourcing Support
Biocardia Announces $4.4 Million Financing
08 Jun 2026 //
GLOBENEWSWIRE
FDA Backs CardiAMP HF II Path to Approval for Ischemic HFrEF
05 Jun 2026 //
GLOBENEWSWIRE
BioCardia Gets Japan PMDA Nod for CardiAMP Cell Therapy for IHF
28 May 2026 //
GLOBENEWSWIRE
BioCardia Reports Exercise Gains in CardiAMP Trial at EuroPCR
21 May 2026 //
GLOBENEWSWIRE
BioCardia to Join AGP Healthcare Company Showcase Fireside
19 May 2026 //
GLOBENEWSWIRE
BioCardia Reports Q1 2026 Business Highlights and Results
15 May 2026 //
GLOBENEWSWIRE
Biocardia To Host Q1 2026 Financial Results Conference Call
11 May 2026 //
GLOBENEWSWIRE
BioCardia, FDA Align on Helix Catheter Clearance Pathway
08 May 2026 //
GLOBENEWSWIRE
Biocardia Allows Japanese Patent For Heart3D Imaging Software
28 Apr 2026 //
GLOBENEWSWIRE
BioCardia, PMDA Agree on CardiAMP Data for Ischemic Heart Failure
20 Apr 2026 //
GLOBENEWSWIRE
BioCardia Files Request for Meeting With FDA to for CardiAMP
02 Apr 2026 //
GLOBENEWSWIRE
Biocardia Reports 2025 Business Highlights And Financial Results
24 Mar 2026 //
GLOBENEWSWIRE
Biocardia`s Helix Catheter Pre-Submission Approved By FDA
17 Mar 2026 //
GLOBENEWSWIRE
Biocardia Presents CardiAMP HF Trial Echocardiography Results
03 Mar 2026 //
GLOBENEWSWIRE
BioCardia Files Pre-FDA Submission for Helix Heart Catheter
10 Feb 2026 //
GLOBENEWSWIRE
Biocardia Unveils Cardiamp HF Trial Echocardiography Results
03 Feb 2026 //
GLOBENEWSWIRE
BioCardia Cell Therapy for Ischemic Heart Failure to Progress
16 Dec 2025 //
GLOBENEWSWIRE
BioCardia Names Slosman CEO as Krasno Steps Down
03 Dec 2025 //
GLOBENEWSWIRE
BioCardia to Present at 2025 CSI Heart Failure Focus
01 Dec 2025 //
GLOBENEWSWIRE
Biocardia Appoints Farhan Shahab As VP Of Quality
24 Nov 2025 //
GLOBENEWSWIRE
Biocardia Highlights Q3 2025 Business & Financial Results
12 Nov 2025 //
GLOBENEWSWIRE
Biocardia Enrolls First Patient In Phase 3 CardiAMP HF II Trial
10 Nov 2025 //
GLOBENEWSWIRE
Biocardia To Host Q3 2025 Corporate Update Conference Call
05 Nov 2025 //
GLOBENEWSWIRE
Biocardia Enrolls First Patient In Phase 3 Cardiamp HF II Trial
30 Oct 2025 //
GLOBENEWSWIRE
Biocardia Regains Compliance With Nasdaq Listing Requirements
02 Oct 2025 //
GLOBENEWSWIRE
Biocardia Reports Positive Consultation With Japan Pmda
22 Sep 2025 //
GLOBENEWSWIRE
Biocardia Reveals Positive Results in CardiAMP Ischemia Trial
18 Sep 2025 //
GLOBENEWSWIRE
BioCardia Prices Up To $12M Public Offering
18 Sep 2025 //
GLOBENEWSWIRE
Biocardia CEO to Present at H.C. Wainwright Investment Conference
04 Sep 2025 //
GLOBENEWSWIRE
BioCardia, CART-Tech Partner on Heart3D Image in Cardiology
13 Aug 2025 //
GLOBENEWSWIRE
BioCardia`s Q2 2025 Business Highlights and Financial Results
11 Aug 2025 //
GLOBENEWSWIRE
BioCardia Schedules Q2 2025 Update and Financial Results Call
06 Aug 2025 //
GLOBENEWSWIRE
Bio Cardia Updates on FDA, Japan PMDA Approval Timing
04 Aug 2025 //
GLOBENEWSWIRE
BioCardia Seeks Japan PMDA Review for CardiAMP Therapy Approval
24 Jul 2025 //
GLOBENEWSWIRE
Henry Ford Begins CardiAMP HF II Ischemic HF Study
16 Jul 2025 //
GLOBENEWSWIRE
BioCardia Secures U.S. Patent for Helix Drug Delivery Device
25 Jun 2025 //
GLOBENEWSWIRE
BioCardia to Join Fireside Chat at A.G.P. Virtual Health Showcase
21 May 2025 //
GLOBENEWSWIRE
BioCardia Reports Q1 2025 Business Highlights and Results
14 May 2025 //
GLOBENEWSWIRE
BioCardia to Host Q1 2025 Corporate Update Call on May 14, 2025
09 May 2025 //
GLOBENEWSWIRE
BioCardia Enrolls CardiAMP HF II Study Patient
06 May 2025 //
GLOBENEWSWIRE
BioCardia starts Phase 3 trial for heart failure Cell therapy
01 May 2025 //
GLOBENEWSWIRE
BioCardia Reports Positive Ph1/2 Review for Heart Therapy
15 Apr 2025 //
GLOBENEWSWIRE
BioCardia starts patient enrollment at Emory for CardiAMP HF II Study
11 Apr 2025 //
GLOBENEWSWIRE
Biocardia Phase 3 CardiAMP-HF Trial Shows Improved Outcomes
31 Mar 2025 //
GLOBENEWSWIRE
BioCardia`s Conference Call on March 31, 2025 at 4:30PM EDT
31 Mar 2025 //
GLOBENEWSWIRE
BioCardia Reports 2024 Business Highlights and Financial Results
26 Mar 2025 //
GLOBENEWSWIRE
BioCardia to Host 2024 Financial Results Call on March 31, 2025
21 Mar 2025 //
GLOBENEWSWIRE
BioCardia announces Japan patent for Helix Bio Delivery System
10 Mar 2025 //
GLOBENEWSWIRE
BioCardia Freezes Data for CardiAMP Heart Failure Trial Presentat
27 Feb 2025 //
GLOBENEWSWIRE
BioCardia Completes Dose Cohort Enrollment for BCDA-03 HFrEF Trial
13 Feb 2025 //
GLOBENEWSWIRE
BioCardia To Present CardiAMP Trial Data At ACC 2025
27 Jan 2025 //
GLOBENEWSWIRE
BioCardia Announces Availability of Morph DNA Steerable Introducer
17 Dec 2024 //
GLOBENEWSWIRE
BioCardia Announces Positive Consultation on CardiAMP Therapy
04 Dec 2024 //
GLOBENEWSWIRE
BioCardia Reports Q3 2024 Business Highlights & Financial Results
13 Nov 2024 //
GLOBENEWSWIRE
BioCardia to Host Q3 2024 Corporate Update & Financial Results
06 Nov 2024 //
GLOBENEWSWIRE
BioCardia Completes Ph III Trial of Cell Therapy for Heart Failure
28 Oct 2024 //
#N/A
BioCardia Regains Full Compliance with Nasdaq Listing Requirements
18 Sep 2024 //
GLOBENEWSWIRE
BioCardia Announces Closes $7.2 Million Public Offering
09 Sep 2024 //
GLOBENEWSWIRE
BioCardia Announces Pricing Of Upsized $7.2M Public Offering
30 Aug 2024 //
GLOBENEWSWIRE
BioCardia Receives FDA Clearance for Morph® DNA™ Steerable Introducer Product
29 Aug 2024 //
GLOBENEWSWIRE
